A framework to guide dose & regimen strategy for clinical drug development.
CPT Pharmacometrics Syst Pharmacol
; 10(11): 1276-1280, 2021 11.
Article
de En
| MEDLINE
| ID: mdl-34562310
ABSTRACT
Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance of risks and benefits is challenging and requires a multidisciplinary approach. In this paper, we present a framework developed as a tool for organizing knowledge and facilitating collaboration in development teams.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Développement de médicament
Type d'étude:
Prognostic_studies
Limites:
Humans
Langue:
En
Journal:
CPT Pharmacometrics Syst Pharmacol
Année:
2021
Type de document:
Article
Pays d'affiliation:
Suisse